In addition, ROC curves of six prognosis-related DEGs indicated that CXCL1 and FABP4 had high accuracies in predicting survival in colon cancer patients (AUC >0.9; Figures 5(c) and 5(d)). This evidence concerns the gene FABP4 and colonic neoplasm.